111
Views
14
CrossRef citations to date
0
Altmetric
Review

Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances

Pages 1157-1163 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

B. Pomahacova, F. Van der Kooy & R. Verpoorte. (2009) Cannabis smoke condensate III: The cannabinoid content of vaporised Cannabis sativa. Inhalation Toxicology 21:13, pages 1108-1112.
Read now
Eva de Lago, María Gómez-Ruiz, Miguel Moreno-Martet & Javier Fernández-Ruiz. (2009) Cannabinoids, multiple sclerosis and neuroprotection. Expert Review of Clinical Pharmacology 2:6, pages 645-660.
Read now
Anna Maria Malfitano, Maria Chiara Proto & Maurizio Bifulco. (2008) Cannabinoids in the management of spasticity associated with multiple sclerosis. Neuropsychiatric Disease and Treatment 4:5, pages 847-853.
Read now

Articles from other publishers (11)

Yiwen Zheng & Paul F. Smith. (2019) Cannabinoid drugs: will they relieve or exacerbate tinnitus?. Current Opinion in Neurology 32:1, pages 131-136.
Crossref
Sebastian Schimrigk, Martin Marziniak, Christine Neubauer, Eva Maria Kugler, Gudrun Werner & Dimitri Abramov-Sommariva. (2017) Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients. European Neurology 78:5-6, pages 320-329.
Crossref
John C. Ashton, Megan J. Dowie & Michelle Glass. 2017. The Endocannabinoid System. The Endocannabinoid System 115 186 .
Paul F. Smith & Yiwen Zheng. (2016) Cannabinoids, cannabinoid receptors and tinnitus. Hearing Research 332, pages 210-216.
Crossref
David Myland Kaufman & Mark J. Milstein. 2013. Kaufman's Clinical Neurology for Psychiatrists. Kaufman's Clinical Neurology for Psychiatrists 329 349 .
Verena Isabell Leussink, Leila Husseini, Clemens Warnke, Erasmia Broussalis, Hans-Peter Hartung & Bernd C. Kieseier. (2012) Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. Therapeutic Advances in Neurological Disorders 5:5, pages 255-266.
Crossref
Paul F. Smith. 2011. Textbook of Tinnitus. Textbook of Tinnitus 639 647 .
Emma L Scotter, Mary E Abood & Michelle Glass. (2010) The endocannabinoid system as a target for the treatment of neurodegenerative disease. British Journal of Pharmacology 160:3, pages 480-498.
Crossref
Antonella Conte, Chiara Marini Bettolo, Emanuela Onesti, Vittorio Frasca, Elisa Iacovelli, Francesca Gilio, Elena Giacomelli, Maria Gabriele, Massimiliano Aragona, Valentina Tomassini, Patrizia Pantano, Carlo Pozzilli & Maurizio Inghilleri. (2012) Cannabinoid‐induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis. European Journal of Pain 13:5, pages 472-477.
Crossref
W. Todd Penberthy. (2009) Nicotinic Acid-Mediated Activation of Both Membrane and Nuclear Receptors towards Therapeutic Glucocorticoid Mimetics for Treating Multiple Sclerosis. PPAR Research 2009, pages 1-11.
Crossref
Mark S. Butler. (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Natural Product Reports 25:3, pages 475.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.